<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2509">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05128500</url>
  </required_header>
  <id_info>
    <org_study_id>MIRAI CLH-1</org_study_id>
    <nct_id>NCT05128500</nct_id>
  </id_info>
  <brief_title>Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI Prosthesis</brief_title>
  <official_title>Prospective Multicentre Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica MIRAI Modular Shoulder Prosthesis System - an Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Permedica spa</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Permedica spa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study is conducted in order to evaluate the effectiveness of the primary&#xD;
      total shoulder arthroplasty with the Permedica's MIRAI Modular Shoulder Prosthesis System on&#xD;
      the general population of patients who are about to undergo this surgery for every&#xD;
      indication. Patients requiring a revision shoulder arthroplasty will not be enrolled.&#xD;
&#xD;
      The effectiveness will be evaluated in terms of recovery of shoulder function and stability&#xD;
      of the prosthetic implant. The incidence of complications, adverse and serious adverse events&#xD;
      will also be studied. Additional study aim is to evaluate a medium/long term survival of the&#xD;
      prosthesis.&#xD;
&#xD;
      The duration of the study per single subject is 5 years.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 12, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical outcome: Change of shoulder function</measure>
    <time_frame>5 years</time_frame>
    <description>Change of &quot;American Shoulder and Elbow Surgeons&quot; (ASES) Score. Total score 0-100 ASES points, 0 = worse pain and functional loss/disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical outcome: Change of shoulder function</measure>
    <time_frame>5 years</time_frame>
    <description>Change of &quot;Disabilities of the Arm, Shoulder and Hand&quot; (DASH) Score. A higher score indicates greater disability. DASH disability/symptom score = [(sum of n responses) - 1]/n x 25, where n is equal to the number of completed responses.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical outcome: Change of shoulder function</measure>
    <time_frame>5 years</time_frame>
    <description>Change of Constant Score. Total score 0-100 Constant points, 0 = worse outcome and functional loss/disability; 100 = better outcome, shoulder function improvement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical outcome: Change of shoulder function</measure>
    <time_frame>5 years</time_frame>
    <description>Change of active Range of Motion (ROM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiological outcome: Radiological implant stability</measure>
    <time_frame>5 years</time_frame>
    <description>Presence of Radiolucent Lines and other radiological signs of instability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological outcome: Radiological implant stability</measure>
    <time_frame>2 years</time_frame>
    <description>Presence of Radiolucent Lines and other radiological signs of instability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Outcome</measure>
    <time_frame>5 years</time_frame>
    <description>Incidence of adverse events and complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant survival rate</measure>
    <time_frame>5 years</time_frame>
    <description>Rate of revisions. Survival estimated with Kaplan-Meier method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant survival rate</measure>
    <time_frame>2 years</time_frame>
    <description>Implant failures. Survival estimated with Kaplan-Meier method.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cuff Tear Arthropathy</condition>
  <condition>Primary Osteoarthritis</condition>
  <condition>Secondary Osteoarthritis</condition>
  <condition>Shoulder Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis Shoulder</condition>
  <condition>Psoriatic Arthritis</condition>
  <condition>Fracture, Shoulder</condition>
  <condition>Avascular Necrosis of Humerus</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Total Shoulder Arthroplasty with Permedica's MIRAI</intervention_name>
    <description>Total Shoulder Arthroplasty with Permedica's MIRAI Modular Shoulder Prosthesis System</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are about to undergo a primary total shoulder arthroplasty in daily clinical&#xD;
        practice, referring to one of the project investigator at the study site will be proposed&#xD;
        to partecipate to the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  both genders&#xD;
&#xD;
          -  at least 18 years old of age&#xD;
&#xD;
          -  undergoing a primary total shoulder arthroplasty with MIRAI® Prosthesis System&#xD;
             (anatomic or reverse, stemless or stemmed).&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients requiring a revision shoulder arthroplasty&#xD;
&#xD;
          -  Persistent chronic or acute infections and all septic conditions&#xD;
&#xD;
          -  Persistent osteomyelitis local or systemic&#xD;
&#xD;
          -  Allergy or hypersensitivity to the substances contained in the materials of the&#xD;
             implanted components&#xD;
&#xD;
          -  Acute or chronic neurological and/or musculoskeletal impairment which compromises the&#xD;
             shoulder joint function such as an axillary nerve injury affecting the deltoid muscle&#xD;
&#xD;
          -  Inadequate bone structure which cannot guarantee stability to the prosthetic&#xD;
             components&#xD;
&#xD;
          -  Several vascular, nerve or muscular disorders, which compromise related extremities&#xD;
&#xD;
          -  Marked osteoporosis, osteomalacia&#xD;
&#xD;
          -  Hypotrophy of the periarticular soft tissues&#xD;
&#xD;
          -  Dysmetabolic diseases such as, for example, kidney failure or systemic diseases&#xD;
&#xD;
          -  Muscular insufficiency&#xD;
&#xD;
          -  Active neoplastic or metastatic diseases&#xD;
&#xD;
          -  Any other clinical or physical condition that can invalidate the surgery, the&#xD;
             rehabilitation or the prosthesis stability&#xD;
&#xD;
          -  Patient unwilling or unable to undergo the rehabilitation or to return to follow-up&#xD;
             visits&#xD;
&#xD;
          -  Women in pregnancy, childbearing potential or breastfeeding&#xD;
&#xD;
          -  Involvement in other ongoing studies or clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorenzo Banci</last_name>
    <role>Study Director</role>
    <affiliation>Permedica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea di Croce</last_name>
    <phone>00390399514811</phone>
    <email>andrea.dicroce@permedica.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>go:h - Gelenkchirurgie Orthopädie: Hannover</name>
      <address>
        <city>Hanover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jens Agneskirkner, PD Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Jens Agneskirchner, PD Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Reinbek St. Adolf-Stilt</name>
      <address>
        <city>Reinbek</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas Niemeier, Prof Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Andreas Niemeier, Prof Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ULSS 1 Dolomiti - Distretto di Belluno, Presidio Ospedaliero San Martino di Belluno</name>
      <address>
        <city>Belluno</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Di Fabio, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Stefano Di Fabio, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Poliambulanza - Istituto Ospedaliero</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Zattoni, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Guido Zattoni, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincenzo Morea, Dr Med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopädische Klinik Luzern - OKL</name>
      <address>
        <city>Luzern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Meyer, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Philip Meyer, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Berit Klinik</name>
      <address>
        <city>Speicher</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Bischof, Dr Med</last_name>
    </contact>
    <investigator>
      <last_name>Andreas Bischof, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florian Novak, Dr Med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip Riedmüller, Dr Med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 9, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total Shoulder Arthroplasty</keyword>
  <keyword>Shoulder Prosthesis</keyword>
  <keyword>Observational Study</keyword>
  <keyword>Cuff Tear Arthropathy</keyword>
  <keyword>Shoulder Osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Psoriatic</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Rotator Cuff Tear Arthropathy</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Shoulder Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

